Literature DB >> 2740989

Hyperthyroidism and concurrent thyroid malignancies.

R Rieger1, W Pimpl, S Money, L Rettenbacher, G Galvan.   

Abstract

In a 17-year period 1848 patients with hyperthyroidism were operated on. Fourteen (0.76%) had a coexisting thyroid malignancy. Preoperative scintiscan and pathologic diagnoses were compared: 10 malignancies were in cold nodules, two were unidentifiable preoperatively due to small size, and two were in hot areas. Five patients had papillary cancer, four follicular, three anaplastic, and two medullary. Patients with uninodular toxic goiter had a low rate of associated malignancy (0.27%, 3/1108). In contrast, patients with multinodular toxic goiter had an incidence of 1.63% (11/676). No patient with Graves' disease (n = 64) had a carcinoma. Extensive use of fine-needle aspiration biopsy enabled preoperative diagnosis in a majority of the cases (9/14, 64%). We conclude that the incidence of coexisting thyroid malignancy and hyperthyroidism is rare in our endemic iodine-deficiency goiter area.

Entities:  

Mesh:

Year:  1989        PMID: 2740989

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  9 in total

1.  Toxic adenoma and papillary thyroid carcinoma in a patient with Graves' disease.

Authors:  T M Valenti; E Macchia; R Pisa; M L Bucalo; V Russo; I Colletti; V Compagno; V Abbadi; M Donatelli
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

2.  Thyroid cancer in hyperthyroidism: incidence rates and value of ultrasound-guided fine-needle aspiration biopsy in this patient group.

Authors:  M Sahin; N D Guvener; F Ozer; A Sengul; D Ertugrul; N B Tutuncu
Journal:  J Endocrinol Invest       Date:  2005-10       Impact factor: 4.256

3.  Hyperfunctioning differentiated thyroid carcinoma.

Authors:  M Appetecchia; M Ducci
Journal:  J Endocrinol Invest       Date:  1998-03       Impact factor: 4.256

4.  Risk stratification of 282 differentiated thyroid cancers found incidentally in 1369 total thyroidectomies according to the 2015 ATA guidelines; implications for management and treatment.

Authors:  I Christakis; S Dimas; I D Kafetzis; N Roukounakis
Journal:  Ann R Coll Surg Engl       Date:  2018-02-27       Impact factor: 1.891

5.  Percutaneous intranodular ethanol injection: a new treatment for autonomous thyroid adenoma.

Authors:  A Paracchi; C Ferrari; T Livraghi; E Reschini; R M Macchi; M Bergonzi; P Raineri
Journal:  J Endocrinol Invest       Date:  1992-05       Impact factor: 4.256

6.  Hyperfunctioning solid/trabecular follicular carcinoma of the thyroid gland.

Authors:  Luca Giovanella; Fabrizio Fasolini; Sergio Suriano; Luca Mazzucchelli
Journal:  J Oncol       Date:  2010-08-16       Impact factor: 4.375

7.  Papillary thyroid carcinoma and inflammation.

Authors:  Laura Fugazzola; Carla Colombo; Michela Perrino; Marina Muzza
Journal:  Front Endocrinol (Lausanne)       Date:  2011-12-16       Impact factor: 5.555

8.  Clinical Characteristics and Prognosis of Coexisting Thyroid Cancer in Patients with Graves' Disease: A Retrospective Multicenter Study.

Authors:  Jee Hee Yoon; Meihua Jin; Mijin Kim; A Ram Hong; Hee Kyung Kim; Bo Hyun Kim; Won Bae Kim; Young Kee Shong; Min Ji Jeon; Ho-Cheol Kang
Journal:  Endocrinol Metab (Seoul)       Date:  2021-11-26

9.  The AsSociation Between Type 2 Diabetes Mellitus, Hypothyroidism, and Thyroid Cancer.

Authors:  Željko Zubčić; Anamarija Šestak; Hrvoje Mihalj; Željko Kotromanović; Andrijana Včeva; Tin Prpić; Matej Rezo; Stjepan Grga Milanković; Vjeran Bogović; Ivan Abičić
Journal:  Acta Clin Croat       Date:  2020-06       Impact factor: 0.780

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.